As a result of fulfilment of necessary conditions both, formal and manufacturing, at 4th October BRASTER started mass production of the device. First in the world system helping women to detect breast cancer by self-examination positively passed certifying audit. Thus Company registered medical product in the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of the Republic of Poland.
Audit completion was the last condition necessary to start the mass production of the device. Before, the company gained permission from District Inspector of Building Supervision to start the production of liquid crystal matrices in factory in Szeligi and to start production of electronic and plastic components of device in Rosti factory in Białystok. First batch of devices will get for sale at the country around 19th October.
"The completion of certifying audit is a milestone for us, it allow us to start production of the first batch of Braster device which will get for sale in the second half of October. All indicates that we will deal with our announcement and we will fulfil presented plans according to schedule." – commented Marcin Halicki, President of BRASTER S.A.
The Company's current activities are focused on the intensive promotional campaign of Braster device. The communication strategy assumes the presence of the product both on the Internet (primarily social media, blogging, VOD, display advertising) as well as classic channels (women's press, product placement). Brand Ambassador was known actress Magdalena Różczka.
Braster technology developed by Polish scientists is covered by patent protection in many countries around the world. In the event of effective commercialization of Braster device on the Polish and international markets, the Company's business will generate significant revenue that will have a significant impact on financial performance in the future.